It is a “mixed anaemia”, in which both haemolysis and bone marrow suppression occur simultaneously.18 Clinically, however, the contribution of RBV to anaemia during combination treatment overshadows the effects of IFN on the bone marrow. This evidence concerns the gene IFNA1 and anemia (phenotype).